Quadroiliac Plane Block for Analgesia After Renal Transplantation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-80
SponsorKanuni Sultan Suleyman Training and Research Hospital

About this trial

Renal transplantation is a major abdominal surgical procedure that may cause moderate to severe postoperative pain. Opioids are commonly used as part of multimodal analgesia; however, opioid-related adverse effects such as sedation, respiratory depression, nausea, vomiting, and constipation may delay recovery and mobilization.

The quadroiliac plane block is an ultrasound-guided interfascial plane block performed near the attachment of the quadratus lumborum muscle to the iliac crest. The technique may provide analgesia over a broad lower abdominal area and may reduce postoperative opioid requirements.

This prospective, randomized, double-blind, controlled clinical trial will compare an ultrasound-guided unilateral quadroiliac plane block with surgical wound infiltration in adult patients undergoing renal transplantation. Participants will be randomly assigned to receive either a quadroiliac plane block with 40 mL of 0.25% bupivacaine or surgical wound infiltration with 10 mL of 0.25% bupivacaine.

All participants will receive standardized multimodal analgesia and intravenous patient-controlled analgesia with tramadol. The primary objective is to compare cumulative tramadol consumption during the first 24 hours after surgery. Postoperative pain scores, dermatomal sensory distribution, motor block, nausea, vomiting, sedation, and quality of recovery will also be evaluated.

Eligibility criteria

Qualifiers

Age between 18 and 80 years

American Society of Anesthesiologists physical status I-III

Scheduled to undergo renal transplantation surgery

Ability to understand the study procedures and postoperative assessments

Disqualifiers

Known allergy to bupivacaine or other amide-type local anesthetics

Infection at the planned injection site

Coagulopathy or anticoagulant therapy associated with an unacceptable bleeding risk for regional anesthesia

Sepsis

Trial design

Treatments tested in this trial

  • Ultrasound-Guided Quadroiliac Plane Block
  • Surgical Wound Infiltration With Bupivacaine

Treatment groups

60 Participants
are divided into 2 treatment groups